**Morphologic interpretation:** The peripheral blood smear reveals a significant proportion of blasts (20.2%) with variable nuclear morphology, including prominent nucleoli and coarse chromatin, alongside increased eosinophils and neutrophils. Monoblasts and promonocytes are present, consistent with myeloid lineage involvement. Lymphoblasts are also observed, suggesting a mixed lineage or non-lymphoid origin. The presence of basophilic cytoplasm in many cells, especially eosinophils, and the overall blast count meet diagnostic criteria for acute myeloid leukemia.

**Diagnostic flags:** blasts_present; blast_threshold_met

**Impression:** AML

**Differential considerations:**
- Presence of monoblasts and promonocytes may suggest a myelodysplastic component or a variant of AML.
- Lymphoblasts in the smear may indicate coexisting lymphoid lineage involvement or a mixed lineage leukemia.
- Eosinophilia may be associated with certain AML subtypes or secondary to other conditions, but in this context, it is not sufficient to override the myeloid blast predominance.

**Recommended workup:**
- Perform flow cytometry to confirm lineage and identify immunophenotypic markers.
- Obtain bone marrow biopsy for morphologic and cytogenetic analysis.
- Consider testing for FLT3, NPM1, and other molecular markers to guide therapy.
- Evaluate for secondary malignancies or prior chemotherapy exposure.

## Quantitative Cell Summary

- Fields of view: 50
- Detected cells: 142
- Informative WBCs: 109
- Artefacts/non-WBC detections: 33

| Cell type | Count | % informative WBCs |
|---|---:|---:|
| Neutrophil | 39 | 35.8% |
| Eosinophil | 27 | 24.8% |
| Lymphoblast | 14 | 12.8% |
| Monocyte | 11 | 10.1% |
| Monoblast | 5 | 4.6% |
| Promonocyte | 5 | 4.6% |
| Lymphocyte | 4 | 3.7% |
| Myeloblast | 3 | 2.8% |
| Myelocyte | 1 | 0.9% |

## Agentic Diagnosis
Predicted diagnosis: **AML** (confidence 0.56). Rationale: learned classifier prediction from detection-derived features.

## Cell Grounding

- `img000_c000` in `40_10_1000_AML.png` bbox=[124.06, 265.0, 213.5, 409.5]: Eosinophil (0.90); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img001_c000` in `40_11_1000_AML.png` bbox=[204.5, 279.25, 278.5, 397.25]: Eosinophil (0.89); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img002_c000` in `40_12_1000_AML.png` bbox=[488.0, 233.75, 555.0, 345.75]: Neutrophil (0.94); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c000` in `40_13_1000_AML.png` bbox=[412.5, 343.0, 486.5, 482.0]: Monocyte (0.76); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c001` in `40_13_1000_AML.png` bbox=[182.0, 198.0, 229.5, 280.0]: Lymphoblast (0.55); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c002` in `40_13_1000_AML.png` bbox=[412.5, 343.5, 485.0, 478.5]: Eosinophil (0.31); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img004_c000` in `40_14_1000_AML.png` bbox=[67.38, 397.5, 141.0, 517.5]: Neutrophil (0.94); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img004_c001` in `40_14_1000_AML.png` bbox=[444.5, 168.5, 494.5, 241.0]: Lymphoblast (0.92); nuclear chromatin; nuclear shape; nucleus; cytoplasm.

> **⚠ Flagged for mandatory human review by the reflection agent.** Reason(s): Low classifier confidence and high non-WBC fraction suggest diagnostic uncertainty.
